|
Volumn 21, Issue 13, 2002, Pages 2097-2101
|
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
|
Author keywords
c myc; Chromosome 17; N myc; Neuroblastoma; nm23 H1; nm23 H2
|
Indexed keywords
GENE PRODUCT;
MESSENGER RNA;
NUCLEOSIDE DIPHOSPHATE KINASE A;
PROTEIN NM23 H2;
UNCLASSIFIED DRUG;
ARTICLE;
CARCINOGENESIS;
CHROMOSOME 17Q;
CONTROLLED STUDY;
GENE AMPLIFICATION;
GENE EXPRESSION;
GENE FREQUENCY;
GENE IDENTIFICATION;
GENE OVEREXPRESSION;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
NEUROBLASTOMA;
NORTHERN BLOTTING;
ONCOGENE C MYB;
ONCOGENE C MYC;
PATHOGENESIS;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
RECEPTOR UPREGULATION;
WESTERN BLOTTING;
CHROMOSOMES, HUMAN, PAIR 17;
GENE AMPLIFICATION;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENES, MYC;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
MONOMERIC GTP-BINDING PROTEINS;
NEUROBLASTOMA;
NUCLEOSIDE-DIPHOSPHATE KINASE;
RNA, MESSENGER;
TRANSCRIPTION FACTORS;
TUMOR CELLS, CULTURED;
|
EID: 85047695614
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1205259 Document Type: Article |
Times cited : (66)
|
References (17)
|